Browsing Category
Ocular Delivery
Formulation Development and In Vitro–Ex Vivo Characterization of Hot-Melt Extruded Ciprofloxacin…
This study developed, optimized, characterized, and evaluated bioadhesive, hot-melt extruded (HME), extended-release ocular inserts containing ciprofloxacin hydrochloride (CIP-HCL) to improve the therapeutic outcomes of ocular bacterial infections. The inserts were fabricated with FDA-approved…
Read More...
Read More...
Overcoming Challenges in Ophthalmic Formulations through Polymer Selection – A Closer Look at…
Ophthalmic drug formulations are growing in importance due to the increased prevalence of eye-related disorders such as diabetic retinopathy and macular degeneration.1 However, ocular drug delivery is challenging due to unique anatomical and physiological barriers such as pre-corneal loss factors…
Read More...
Read More...
Cyclodextrin-based ocular drug delivery systems: A comprehensive review
Cyclodextrin (CD), a class of cyclic oligosaccharides with an external hydrophilic surface and a central hydrophobic cavity is recognized as a promising pharmaceutical excipient due to its unique ability to form inclusion complexes with small molecules and polymers. CD has excellent…
Read More...
Read More...
Ophthalmics Process by Merck – Keep a close eye on quality and safety
Reduce risk and overcome challenges
Ophthalmic drugs pose special formulation challenges to manufacturers. In general, choosing the right processes and materials is important to ensure the required quality, drug tolerability and patient adherence. Formulators must pay attention to tonicity, pH,…
Read More...
Read More...
Trends in development and quality assessment of pharmaceutical formulations – F2α analogues in…
The ocular delivery route presents a number of challenges in terms of drug administration and bioavailability. The low bioavailability following topical ophthalmic administration shows that there is a clear need for in-depth research aimed at finding both more efficacious molecules and formulations…
Read More...
Read More...
Novel drug delivery systems for the management of dry eye
Dry eye disease (DED) is a frequently observed eye complaint, which has recently attracted considerable research interest. Conventional therapy for DED involves the use of artificial tear products, cyclosporin, corticosteroids, mucin secretagogues, antibiotics and nonsteroidal anti-inflammatory…
Read More...
Read More...
Recent advancements in polymeric nanofibers for ophthalmic drug delivery and ophthalmic tissue…
Nanofibers due to their unique properties such as high surface-to-volume ratio, porous structure, mechanical strength, flexibility and their resemblance to the extracellular matrix, have been researched extensively in the field of ocular drug delivery and tissue engineering. Further, different…
Read More...
Read More...
Optimization of Lipid Nanoparticles by Response Surface Methodology to Improve the Ocular Delivery…
Diosmin is a flavonoid with a great variety of biological activities including antioxidant and anti-inflammatory ones. Its cytoprotective effect in retinal pigment epithelium cells under high glucose conditions makes it a potential support in the treatment of diabetic retinopathy. Despite its…
Read More...
Read More...
Lipid-based nanocarriers for ocular drug delivery: An updated review
Recent years have witnessed a boom in ocular nanomedicine research with a number of lipid-based nanocarriers such as liposomes, niosomes, cubosomes, nanoemulsions, solid lipid nanoparticles, nanostructured lipid carriers, etc., to improve the ocular bioavailability of a variety of drugs and…
Read More...
Read More...
The emerging role of 3D-printing in ocular drug delivery: Challenges, current status, and future…
The era of the 3D printing technique emerged in 1986. With the advancement of technology, 3D printing analysis has gained massive attention and become widely used in recent years. Modern medicine has needed new advancements to provide the best care, considering the increase in deadly diseases. Thus,…
Read More...
Read More...